한글목차

세계의 폴리에틸렌 글리콜 시장 규모는 2024년 39억 4,000만 달러에서 2029년까지 53억 1,000만 달러에 이를 것으로 예측되며 CAGR로 6.2%의 성장이 예상됩니다. PEG는 의약품을 포함한 다양한 최종 이용 산업에서 다목적 용도가 있습니다. PEG는 제약 산업에서 제제 및 전달 시스템에 널리 사용됩니다. 또한 난용성 약물의 용해성과 생체이용률을 높입니다. 또한 독성이 낮고 자극성이 없기 때문에 화장품 및 퍼스널케어 산업에서 크림, 로션, 목욕 젤 등 다양한 제품의 제조에 널리 사용되고 있습니다.

'등급별로, PEG 400은 예측 기간에 금액 기준으로 가장 빠른 시장이 됩니다.'

PEG 400은 의약품, 화장품 및 퍼스널케어를 비롯한 다양한 산업 분야에서 다양한 용도로 예측 기간에 가장 빠른 시장입니다. 이 등급의 PEG는 저분자량이고 친수성이 높습니다. 이러한 특성은 제형 및 약물 전달 시스템에서 용해도와 생체이용률을 높이는 효과적인 윤활제입니다. 또한, 독성이 낮기 때문에 경구제, 외용제, 주사제의 제조에 사용되어 시장 성장을 뒷받침하고 있습니다. 또한, 비자극적이고 생분해성이기 때문에 크림, 로션, 목욕 젤 등 다양한 제품의 보습제, 윤활제, 용제로 화장품 및 개인 관리 산업에서 매우 사용됩니다.

'패키지 크기별로 벌크 컨테이너는 예측 기간 동안 금액 기준으로 가장 큰 시장이 됩니다.'

벌크 컨테이너는 여러 요소로 인해 패키지 크기별로 가장 큰 시장이 되었습니다. 의약품, 화장품, 퍼스널케어 등의 산업용도에서는 효율적인 제조 공정에 대량의 PEG가 필요합니다. 벌크 컨테이너 포장은 작은 용기에 필요한 취급 및 보관 비용을 최소화하고 제조업체에게 비용 효율적인 보관을 제공합니다. 또한 벌크 컨테이너를 사용하면 산업용 PEG의 배송 빈도를 최소화하고 공급망의 효율을 높일 수 있습니다. 게다가 벌크 컨테이너는 작은 용기에 비해 포장재료가 적기 때문에 재료의 낭비를 최소화할 수 있습니다. 이러한 요인으로 인해 PEG 시장에서는 벌크 컨테이너가 패키지 크기별로 가장 큰 점유율을 차지하고 있습니다.

'지역별로 아시아태평양은 금액 기준으로 PEG의 가장 크고 가장 빠른 성장 시장입니다.'

아시아태평양은 PEG 시장에서 가장 크고 가장 빠르게 성장하는 지역입니다. 이 지역은 특히 중국과 인도와 같은 국가에서 의약품, 화장품, 개인 관리 및 기타 산업이 급속히 확대되고 있습니다. 이 지역에서는 제형, 약물 전달 시스템, 화장품, 화학 제제 등 다양한 용도로 PEG 수요가 증가하고 있습니다. 게다가 이 지역의 인구 증가는 의료의 확대를 가져오고 제약산업에서의 PEG 소비를 뒷받침하고 있습니다. 사람들의 가처분 소득 증가는 화장품 및 퍼스널케어 제품에서 PEG 사용에 박차를 가하고 있습니다. 또한 주요 제조업체의 존재, 낮은 생산 비용 및 유리한 정부 정책이 이 지역 시장 성장을 가속화하고 있습니다. 아시아태평양에서는 산업화와 도시화가 진행되고 있으며 PEG 시장의 성장이 예측됩니다.

이 보고서는 세계의 폴리에틸렌 글리콜 시장에 대한 조사 분석을 통해 주요 촉진요인 및 억제요인, 경쟁 구도, 미래 동향 등의 정보를 제공합니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

• 폴리에틸렌 글리콜 시장의 기업에게 매력적인 기회
• 폴리에틸렌 글리콜 시장 : 형상별
• 폴리에틸렌 글리콜 시장 : 등급별
• 폴리에틸렌 글리콜 시장 : 패키지 사이즈별
• 폴리에틸렌 글리콜 시장 : 최종 이용 산업별
• 폴리에틸렌 글리콜 시장 : 주요 국가별

제5장 시장 개요

• 서문
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 과제
• Porter's Five Forces 분석
• 주요 이해관계자와 구매 기준
  • 구매 과정에서 주요 이해 관계자
  • 품질
  • 서비스
• 거시경제 전망
• AI 및 생성형 AI의 영향
• 밸류체인 분석
  • 원재료 공급자
  • 제조업체
  • 판매자
  • 최종 사용자
• 생태계 분석
• 규제 상황
  • 환경규제
  • 북미
  • 아시아태평양
  • 유럽
  • 규제기관, 정부기관, 기타 조직
• 기술 분석
  • 주요 기술
  • 보완 기술
• 고객사업에 영향을 주는 동향 및 혼란
• 무역 분석
  • 수입 시나리오(HS 코드 291010)
  • 수출 시나리오(HS 코드 291010)
  • 수입 시나리오(HS 코드 340420)
  • 수출 시나리오(HS 코드 340420)
• 주된 회의 및 이벤트(2024-2025년)
• 가격 분석
  • 평균 판매 가격의 동향 : 지역별(2022-2029년)
  • 평균 판매 가격의 동향 : 최종 이용 산업별(2023년)
  • 주요 기업의 평균 판매 가격 동향 : 최종 이용 산업별(2023년)
• 투자 및 자금조달 시나리오
• 특허 분석
  • 서문
  • 문헌의 유형
  • 과거 10년간의 공보의 동향
  • 고찰
  • 법적 지위
  • 관할분석
  • 주요 출원자
• 사례 연구 분석

제6장 폴리에틸렌 글리콜 시장 : 형상별

• 서문
• 액체
• 흰 납땜 고체
• 플레이크 및 파우더

제7장 폴리에틸렌 글리콜 시장 : 등급별

• 서문
• PEG 200
• PEG 400
• PEG 1000
• PEG 3350
• PEG 4000
• PEG 6000
• PEG 8000
• 기타 등급

제8장 폴리에틸렌 글리콜 시장 : 패키지 사이즈별

• 서문
• 드럼
• 벌크 컨테이너
• 유리병
• 기타 패키지 사이즈

제9장 폴리에틸렌 글리콜 시장 : 최종 이용 산업별

• 서문
• 제약
• 화장품 및 퍼스널케어
• 식품 및 음료
• 공업
• 기타 최종 이용 산업

제10장 폴리에틸렌 글리콜 시장 : 지역별

• 서문
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 한국
  • 인도네시아
  • 호주
  • 기타 아시아태평양
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타 유럽
• 중동 및 아프리카
  • GCC
  • 남아프리카
  • 기타 중동 및 아프리카
• 남미
  • 브라질
  • 아르헨티나
  • 기타 남미

제11장 경쟁 구도

• 개요
• 주요 참가 기업의 전략 및 강점(2019-2024년)
• 수익 분석(2021-2023년)
• 시장 점유율 분석(2023년)
• 기업 평가 및 재무 지표
• 브랜드 및 제품 비교
• 기업의 평가 매트릭스 : 주요 기업(2023년)
• 기업의 평가 매트릭스 : 스타트업 및 중소기업(2023년)
• 경쟁 시나리오 및 동향

제12장 기업 프로파일

• 주요 기업
  • DOW
  • BASF
  • CLARIANT
  • LOTTE CHEMICAL CORPORATION
  • SANYO CHEMICALS INDUSTRIES LTD.
  • SABIC
  • KAO CORPORATION
  • CRODA INTERNATIONAL PLC
  • INDIA GLYCOLS LIMITED
  • INEOS
  • MERCK KGAA
  • INDORAMA VENTURES PUBLIC COMPANY LIMITED
  • NOF CORPORATION
  • AVESTA PHARMA PVT. LTD.
  • SASOL
  • OXITENO
• 기타 기업
  • SPECTRUM CHEMICAL
  • KRAFT CHEMICAL COMPANY
  • LIAONING KELONG FINE CHEMICAL CO., LTD.
  • SHANGHAI BRONKOW CHEMICAL CO., LTD.
  • LIAONING SHENGDE HUAXING CHEMICAL CO. LTD.
  • JIANGSU HAI'AN PETROCHEMICAL PLANT
  • CHEMICAL BULL
  • HUNAN HUATENG PHARMACEUTICAL CO., LTD.
  • MATANGI INDUSTRIES
  • LAYSAN BIO
  • CREATIVE PEGWORKS
  • JENKEM TECHNOLOGY
  • YIXING CLEANWATER CHEMICALS CO., LTD.
  • LIAONING OXIRANCHEM

제13장 부록

영문목차

The PEG market is projected to reach USD 5.31 Billion By 2029, At A CAGR Of 6.2% From USD 3.94 Billion in 2024. PEG have versatile applications among various end-use industries including pharmaceuticals. PEG are widely used for drug formulations and delivery systems in pharmaceutical industries. It enhances the solubility and bioavailability of poorly soluble drugs. Additionally, due to its low toxicity and non-irritating properties it is widely used in cosmetics & personal care industries for manufacturing various products such as creams, lotions and bath gels.

"Based on grade, PEG 400 accounts for the fastest market during the forecast period, in terms of value."

PEG 400 accounts for the fastest market during the forecast period due to its versatility of applications across various range of industries including pharmaceuticals and cosmetics & personal care. This grade of PEG has low molecular weight and high hydrophilicity. These properties make it an effective lubricant for enhancing the solubility and bioavailability in drug formulations and drug delivery systems. Moreover, it is used for manufacturing of oral, topical, and injectable formulations due to its low toxicity which fuels the market growth. Additionally, due to its non-irritating and biodegradable nature it is highly used in cosmetics and personal care industry acting as humectant, lubricant and solvents for different products such as creams, lotions and bath gels.

"Based on package size, bulk container is the largest market during the forecast period, in terms of value."

Bulk containers account for the largest market by package size due to several factors. In industrial applications such as pharmaceuticals and cosmetics & personal care require large quantities of PEG for efficient manufacturing processes. The packaging in bulk containers minimizes the handling and storage costs required for small containers offering cost effective storage for manufacturers. Moreover, using of bulk containers enhance the supply chain efficiency by minimizing the frequency of PEG deliveries for industrial applications. Furthermore, bulk containers minimize the waste of material as it requires less packaging material compared to smaller containers. Collectively, these factors contribute to making bulk containers account largest share by package size in PEG market.

"Based on region, Asia Pacific is the largest and fastest growing market for PEG, in terms of value."

Asia Pacific is the largest and fastest growing region for PEG market. The region has rapidly expanding pharmaceutical, cosmetics & personal care and other industries particularly in countries like China and India. The demand for PEG in various applications such as drug formulation, delivery systems, cosmetics and chemical formulation is rising in the region. Additionally, the region's growing population has resulted into expansion of healthcare boosting the consumption of PEG in pharmaceutical industries. The rising disposable income of people is fueling the use of PEG in cosmetics & personal care products. Furthermore, the presence of major manufacturers, low production costs and favorable government policies accelerate the market growth in the region. As the region continues to industrialize and urbanize, the PEG market is anticipated to grow in the Asia pacific region.

In the process of determining and verifying the market size for several segments and subsegments identified through secondary research, extensive primary interviews were conducted. A breakdown of the profiles of the primary interviewees are as follows:

• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
• By Designation: C-Level - 35%, Director Level - 25%, and Others - 40%
• By Region: North America - 22%, Europe - 22%, Asia Pacific - 45%, Rest of World - 11%

The key players in this market are BASF (Germany), Dow (US), Clariant (Switzerland), Lotte Chemical Corporation (South Korea), Sanyo Chemicals Industries Ltd (Japan), Sabic (Saudi Arabia), Kao Corporation (Japan), Croda International Plc (UK), India Glycols Limited (India), INEOS (India), Merck KGaA (Germany), Indorama Ventures Public Company Limited (Thailand), NOF Corporation (Japan) and Spectrum Chemical (US).

Research Coverage

This report segments the PEG market based on grade, form, end-use industry, package size and region, and provides estimations for the overall value of the market across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products and services, key strategies, new product launches, expansions, and mergers & acquisitions associated with the PEG market.

Key benefits of buying this report

This research report focuses on various levels of analysis, including industry analysis (industry trends), market ranking analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the PEG market, high-growth regions, and market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (Growing demand for medicines, advancement in drug delivery technologies, expansion of cosmetics & personal care, rising prevalence of chronic diseases), restraints (Fluctuating raw material prices, environmental safety and issues, concerns over immunogenicity), opportunities (Expansion of personalized medicines, increasing demand for long-acting medications, 3-D printing and bio fabrication) and challenges (Product performance limitations, degradation Issues).
• Market Penetration: Comprehensive information on the PEG market offered by top players in the global PEG market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the PEG market.
• Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for PEG market across regions.
• Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global PEG market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the PEG market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 UNITS CONSIDERED
• 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Primary interviews-demand and supply side
    • 2.1.2.3 Key industry insights
    • 2.1.2.4 Breakdown of interviews with experts
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 GROWTH FORECAST
• 2.4 DATA TRIANGULATION
• 2.5 FACTOR ANALYSIS
• 2.6 ASSUMPTIONS
• 2.7 LIMITATIONS & RISKS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN POLYETHYLENE GLYCOL MARKET
• 4.2 POLYETHYLENE GLYCOL MARKET, BY FORM
• 4.3 POLYETHYLENE GLYCOL MARKET, BY GRADE
• 4.4 POLYETHYLENE GLYCOL MARKET, BY PACKAGE SIZE
• 4.5 POLYETHYLENE GLYCOL MARKET, BY END-USE INDUSTRY
• 4.6 POLYETHYLENE GLYCOL MARKET, BY KEY COUNTRY

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing demand for medicines for chronic disease management
    • 5.2.1.2 Advancements in drug delivery technologies
    • 5.2.1.3 Expansion of cosmetics and personal care industries
    • 5.2.1.4 Growing demand for bio-based polyethylene glycol
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Fluctuating raw material prices
    • 5.2.2.2 Environmental safety and issues
    • 5.2.2.3 Concerns over immunogenicity
    • 5.2.2.4 Competition from substitute products
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Increasing demand for personalized medicines for biologics and precision therapies
    • 5.2.3.2 Innovations in 3D printing and bio-fabrication
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Limitations related to product performance
    • 5.2.4.2 Degradation issues concerning polyethylene-based drug formulations
• 5.3 PORTER'S FIVE FORCES ANALYSIS
  • 5.3.1 THREAT FROM NEW ENTRANTS
  • 5.3.2 THREAT FROM SUBSTITUTES
  • 5.3.3 BARGAINING POWER OF SUPPLIERS
  • 5.3.4 BARGAINING POWER OF BUYERS
  • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.4 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.4.2 QUALITY
  • 5.4.3 SERVICE
• 5.5 MACROECONOMIC OUTLOOK
  • 5.5.1 GDP TRENDS AND FORECASTS
• 5.6 IMPACT OF AI/GENAI
• 5.7 VALUE CHAIN ANALYSIS
  • 5.7.1 RAW MATERIAL SUPPLIERS
  • 5.7.2 MANUFACTURERS
  • 5.7.3 DISTRIBUTORS
  • 5.7.4 END USERS
• 5.8 ECOSYSTEM ANALYSIS
• 5.9 REGULATORY LANDSCAPE
  • 5.9.1 ENVIRONMENTAL REGULATIONS
  • 5.9.2 NORTH AMERICA
  • 5.9.3 ASIA PACIFIC
  • 5.9.4 EUROPE
  • 5.9.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.10 TECHNOLOGY ANALYSIS
  • 5.10.1 KEY TECHNOLOGIES
    • 5.10.1.1 Smart PEGylation
    • 5.10.1.2 Nanotechnology
    • 5.10.1.3 Controlled-release drug delivery
  • 5.10.2 COMPLEMENTARY TECHNOLOGIES
    • 5.10.2.1 PEG hydrogels in bioprinting
    • 5.10.2.2 Random polyethylene glycol
• 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.12 TRADE ANALYSIS
  • 5.12.1 IMPORT SCENARIO (HS CODE 291010)
  • 5.12.2 EXPORT SCENARIO (HS CODE 291010)
  • 5.12.3 IMPORT SCENARIO (HS CODE 340420)
  • 5.12.4 EXPORT SCENARIO (HS CODE 340420)
• 5.13 KEY CONFERENCES AND EVENTS, 2024-2025
• 5.14 PRICING ANALYSIS
  • 5.14.1 AVERAGE SELLING PRICE TREND, BY REGION, 2022-2029
  • 5.14.2 AVERAGE SELLING PRICE TREND, BY END-USE INDUSTRY, 2023
  • 5.14.3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END-USE INDUSTRY, 2023
• 5.15 INVESTMENT AND FUNDING SCENARIO
• 5.16 PATENT ANALYSIS
  • 5.16.1 INTRODUCTION
  • 5.16.2 DOCUMENT TYPES
  • 5.16.3 PUBLICATION TRENDS IN LAST 10 YEARS
  • 5.16.4 INSIGHTS
  • 5.16.5 LEGAL STATUS
  • 5.16.6 JURISDICTION ANALYSIS
  • 5.16.7 TOP APPLICANTS
• 5.17 CASE STUDY ANALYSIS
  • 5.17.1 UNILEVER DEVELOPS SKINCARE FORMULATIONS TO ENHANCE MOISTURIZING EFFECT AND BOOST BRAND LOYALTY
  • 5.17.2 BASF DEVELOPS POLYURETHANE FOAMS TO REDUCE HEAT LOSS IN BUILDINGS AND IMPROVE CUSHIONING IN AUTOMOBILE SEATS
  • 5.17.3 MERCK KGAA DEVELOPES DRUG DELIVERY SYSTEMS TO ENHANCE BIOAVAILABILITY OF TARGETED THERAPEUTIC MOLECULES

6 POLYETHYLENE GLYCOL MARKET, BY FORM

• 6.1 INTRODUCTION
• 6.2 LIQUID
  • 6.2.1 USED AS HUMECTANT AND EMULSIFIER FOR RETAINING MOISTURE AND STABILIZING FORMULATIONS
• 6.3 WHITE WAX SOLID
  • 6.3.1 EXTENSIVE USE IN DERMATOLOGICAL APPLICATIONS
• 6.4 FLAKE/POWDER
  • 6.4.1 WIDE APPLICATIONS IN SOLID AND SEMI-SOLID FORMULATIONS

7 POLYETHYLENE GLYCOL MARKET, BY GRADE

• 7.1 INTRODUCTION
• 7.2 PEG 200
  • 7.2.1 EXCELLENT WATER SOLUBILITY ENSURING UNIFORM DISTRIBUTION OF ACTIVE PHARMACEUTICAL INGREDIENTS
• 7.3 PEG 400
  • 7.3.1 WIDELY PREFERRED IN PHARMACEUTICAL INDUSTRY TO IMPROVE MOISTURE RETENTION AND ENHANCE TEXTURE
• 7.4 PEG 1000
  • 7.4.1 HIGH DEMAND IN COSMETICS AND DRUG FORMULATIONS TO ENHANCE SOLUBILITY AND BIOAVAILABILITY OF DRUGS
• 7.5 PEG 3350
  • 7.5.1 WIDELY USED AS OSMOTIC LAXATIVE IN PHARMACEUTICAL INDUSTRY
• 7.6 PEG 4000
  • 7.6.1 INCREASING DEMAND IN CONTROLLED DRUG DELIVERY SYSTEMS TO IMPROVE OVERALL PRODUCT STABILITY
• 7.7 PEG 6000
  • 7.7.1 WIDE APPLICATION AS BINDER AND THICKENING AGENT IN TABLET AND CAPSULE FORMULATIONS
• 7.8 PEG 8000
  • 7.8.1 EXTENSIVE USE IN BIOMEDICAL APPLICATIONS AND ELASTOMER FORMATION
• 7.9 OTHER GRADES

8 POLYETHYLENE GLYCOL MARKET, BY PACKAGE SIZE

• 8.1 INTRODUCTION
• 8.2 DRUMS
  • 8.2.1 WIDELY USED FOR PEG 200 AND PEG 400 IN LARGE-SCALE PHARMACEUTICAL APPLICATIONS
• 8.3 BULK CONTAINERS
  • 8.3.1 REDUCE FREQUENCY OF REORDERING AND MINIMIZE PACKAGING WASTE
• 8.4 GLASS BOTTLES
  • 8.4.1 INCREASING DEMAND IN PHARMACEUTICAL AND COSMETIC INDUSTRIES
• 8.5 OTHER PACKAGE SIZES

9 POLYETHYLENE GLYCOL MARKET, BY END-USE INDUSTRY

• 9.1 INTRODUCTION
• 9.2 PHARMACEUTICAL
  • 9.2.1 RISING DEMAND FOR POLYETHYLENE GLYCOL IN DRUG DELIVERY SYSTEMS TO DRIVE MARKET
• 9.3 COSMETICS & PERSONAL CARE
  • 9.3.1 PRESSING NEED FOR EXTENDING SHELF LIFE OF COSMETIC FORMULATIONS TO BOOST DEMAND
• 9.4 FOOD & BEVERAGE
  • 9.4.1 WIDE APPLICATIONS IN FOOD PROCESSING AND PRESERVATION TECHNIQUES TO DRIVE MARKET
• 9.5 INDUSTRIAL
  • 9.5.1 INCREASING DEMAND IN METALWORKING AND PLASTIC PRODUCTION TO DRIVE MARKET
• 9.6 OTHER END-USE INDUSTRIES

10 POLYETHYLENE GLYCOL MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 US
    • 10.2.1.1 Robust demand from pharmaceutical industry to drive market
  • 10.2.2 CANADA
    • 10.2.2.1 Innovations and technological advancements to drive market
  • 10.2.3 MEXICO
    • 10.2.3.1 Favorable regulatory environment for trade to increase demand for polyethylene glycol
• 10.3 ASIA PACIFIC
  • 10.3.1 CHINA
    • 10.3.1.1 Rising investments in healthcare to fuel market
  • 10.3.2 INDIA
    • 10.3.2.1 Rapid population and industrial growth to drive market
  • 10.3.3 JAPAN
    • 10.3.3.1 Innovation in biologics and personalized medicines to drive market
  • 10.3.4 SOUTH KOREA
    • 10.3.4.1 Growth of cosmetics & personal care industry to boost demand for polyethylene glycol
  • 10.3.5 INDONESIA
    • 10.3.5.1 Expansion of healthcare sector to drive market
  • 10.3.6 AUSTRALIA
    • 10.3.6.1 Increasing investments in drug developments to drive market
  • 10.3.7 REST OF ASIA PACIFIC
• 10.4 EUROPE
  • 10.4.1 GERMANY
    • 10.4.1.1 Pressing need for injectables and laxatives to drive market
  • 10.4.2 UK
    • 10.4.2.1 Expansion of pharmaceutical and healthcare companies to drive market
  • 10.4.3 FRANCE
    • 10.4.3.1 Rise in elderly population to boost demand for advanced healthcare solutions
  • 10.4.4 ITALY
    • 10.4.4.1 Expansion of cosmetics & personal care industry to drive market
  • 10.4.5 SPAIN
    • 10.4.5.1 Increasing consumer spending on cosmetics & personal care products to drive market
  • 10.4.6 REST OF EUROPE
• 10.5 MIDDLE EAST & AFRICA
  • 10.5.1 GCC
    • 10.5.1.1 Saudi Arabia
      • 10.5.1.1.1 Rise in infrastructural development to boost market
    • 10.5.1.2 UAE
      • 10.5.1.2.1 Rapid industrial expansion to drive demand for polyethylene glycol
    • 10.5.1.3 Rest of GCC
  • 10.5.2 SOUTH AFRICA
    • 10.5.2.1 Rising chronic disease rate to boost demand for effective drug formulations
  • 10.5.3 REST OF MIDDLE EAST & AFRICA
• 10.6 SOUTH AMERICA
  • 10.6.1 BRAZIL
    • 10.6.1.1 Diverse applications in end-use industries to drive market
  • 10.6.2 ARGENTINA
    • 10.6.2.1 Improving economic conditions to drive demand
  • 10.6.3 REST OF SOUTH AMERICA

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2019-2024
• 11.3 REVENUE ANALYSIS, 2021-2023
• 11.4 MARKET SHARE ANALYSIS, 2023
• 11.5 COMPANY VALUATION AND FINANCIAL METRICS
• 11.6 BRAND/PRODUCT COMPARISON
• 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 11.7.1 STARS
  • 11.7.2 EMERGING LEADERS
  • 11.7.3 PERVASIVE PLAYERS
  • 11.7.4 PARTICIPANTS
  • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 11.7.5.1 Company footprint
    • 11.7.5.2 Region footprint
    • 11.7.5.3 Grade footprint
    • 11.7.5.4 End-use industry footprint
    • 11.7.5.5 Form footprint
    • 11.7.5.6 Package size footprint
• 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 11.8.1 PROGRESSIVE COMPANIES
  • 11.8.2 RESPONSIVE COMPANIES
  • 11.8.3 DYNAMIC COMPANIES
  • 11.8.4 STARTING BLOCKS
  • 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 11.8.5.1 Detailed list of key startups/SMEs
    • 11.8.5.2 Competitive benchmarking of key startups/SMEs
• 11.9 COMPETITIVE SCENARIO AND TRENDS
  • 11.9.1 PRODUCT LAUNCHES
  • 11.9.2 DEALS
  • 11.9.3 EXPANSIONS
  • 11.9.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 DOW
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products/Solutions/Services offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Expansions
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses and competitive threats
  • 12.1.2 BASF
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products/Solutions/Services offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Expansions
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses and competitive threats
  • 12.1.3 CLARIANT
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products/Solutions/Services offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Product launches
      • 12.1.3.3.2 Deals
      • 12.1.3.3.3 Expansions
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses and competitive threats
  • 12.1.4 LOTTE CHEMICAL CORPORATION
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products/Solutions/Services offered
    • 12.1.4.3 MnM view
      • 12.1.4.3.1 Key strengths
      • 12.1.4.3.2 Strategic choices
      • 12.1.4.3.3 Weaknesses and competitive threats
  • 12.1.5 SANYO CHEMICALS INDUSTRIES LTD.
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products/Solutions/Services offered
    • 12.1.5.3 MnM view
      • 12.1.5.3.1 Key strengths
      • 12.1.5.3.2 Strategic choices
      • 12.1.5.3.3 Weaknesses and competitive threats
  • 12.1.6 SABIC
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products/Solutions/Services offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Others
    • 12.1.6.4 MnM view
  • 12.1.7 KAO CORPORATION
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products/Solutions/Services offered
    • 12.1.7.3 MnM view
  • 12.1.8 CRODA INTERNATIONAL PLC
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products/Solutions/Services offered
    • 12.1.8.3 MnM view
  • 12.1.9 INDIA GLYCOLS LIMITED
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products/services/solutions offered
  • 12.1.10 INEOS
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products/services/solutions offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Expansions
  • 12.1.11 MERCK KGAA
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products/Solutions/Services offered
  • 12.1.12 INDORAMA VENTURES PUBLIC COMPANY LIMITED
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products/Solutions/Services offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Deals
  • 12.1.13 NOF CORPORATION
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products/Solutions/Services offered
  • 12.1.14 AVESTA PHARMA PVT. LTD.
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products/Solutions/Services offered
    • 12.1.14.3 Recent developments
    • 12.1.14.4 MnM view
      • 12.1.14.4.1 Key strengths
      • 12.1.14.4.2 Strategic choices
      • 12.1.14.4.3 Weaknesses and competitive threats
  • 12.1.15 SASOL
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products/Solutions/Services offered
    • 12.1.15.3 MnM view
      • 12.1.15.3.1 Key strengths
      • 12.1.15.3.2 Strategic choices
      • 12.1.15.3.3 Weaknesses and competitive threats
  • 12.1.16 OXITENO
    • 12.1.16.1 Business overview
    • 12.1.16.2 Products/Solutions/Services offered
    • 12.1.16.3 Recent developments
    • 12.1.16.4 MnM view
      • 12.1.16.4.1 Key strengths
      • 12.1.16.4.2 Strategic choices
      • 12.1.16.4.3 Weaknesses and competitive threats
• 12.2 OTHER PLAYERS
  • 12.2.1 SPECTRUM CHEMICAL
  • 12.2.2 KRAFT CHEMICAL COMPANY
  • 12.2.3 LIAONING KELONG FINE CHEMICAL CO., LTD.
  • 12.2.4 SHANGHAI BRONKOW CHEMICAL CO., LTD.
  • 12.2.5 LIAONING SHENGDE HUAXING CHEMICAL CO. LTD.
  • 12.2.6 JIANGSU HAI'AN PETROCHEMICAL PLANT
  • 12.2.7 CHEMICAL BULL
  • 12.2.8 HUNAN HUATENG PHARMACEUTICAL CO., LTD.
  • 12.2.9 MATANGI INDUSTRIES
  • 12.2.10 LAYSAN BIO
  • 12.2.11 CREATIVE PEGWORKS
  • 12.2.12 JENKEM TECHNOLOGY
  • 12.2.13 YIXING CLEANWATER CHEMICALS CO., LTD.
  • 12.2.14 LIAONING OXIRANCHEM

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 RELATED REPORTS
• 13.4 AUTHOR DETAILS 2901 INTRODUCTION